StockWatch
·
Pharmaceuticals
Board Meeting22 Oct 2026, 11:42 am

Ipca Laboratories Board Meeting on Nov 5, 2026 for Q2 FY27 Results

AI Summary

Ipca Laboratories has announced a Board of Directors meeting scheduled for November 5, 2026. The primary agenda is to consider and approve the standalone and consolidated unaudited financial results for the second quarter and half-year ended September 30, 2026. The company also confirmed that the trading window for insiders will remain closed from October 1, 2026, until 48 hours after the declaration of these financial results, closing on November 7, 2026.

Key Highlights

  • Board meeting scheduled for November 5, 2026.
  • To approve Q2 FY27 standalone and consolidated financial results.
  • Financial results period: Q2 and H1 ended September 30, 2026.
  • Trading window closure extended until November 7, 2026.
  • Notice issued as per SEBI Listing Obligations and Disclosure Requirements.